| Predicate |
Object |
| contentType |
Journal Article|Research Support, N.I.H., Extramural|Review |
| endingPage |
69 |
| issn |
0065-2598 |
| pageRange |
55-69 |
| publicationName |
Advances in experimental medicine and biology |
| startingPage |
55 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c39967f7ff994dad1056076773e04368
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae238daacd815b12a06f99258495b043 |
| bibliographicCitation |
Kawate T. P2X Receptor Activation. Adv Exp Med Biol. 2017;1051():55–69. doi: 10.1007/5584_2017_55. PMID: 28639248. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54ceaca16aa7d28f2125bbf2b371fd45 |
| date |
2017 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/28639248
https://doi.org/10.1007/5584_2017_55 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0065-2598
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/280 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
P2X Receptor Activation |
| discusses |
http://id.nlm.nih.gov/mesh/M0542610
http://id.nlm.nih.gov/mesh/M0000395 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D058469Q000235
http://id.nlm.nih.gov/mesh/D058469Q000378
http://id.nlm.nih.gov/mesh/D058469Q000737
http://id.nlm.nih.gov/mesh/D015640Q000502 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000072417
http://id.nlm.nih.gov/mesh/D018360
http://id.nlm.nih.gov/mesh/D000255Q000235
http://id.nlm.nih.gov/mesh/D000255Q000378
http://id.nlm.nih.gov/mesh/D021281
http://id.nlm.nih.gov/mesh/D000818 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3310f243507cb1744ab3833b4c862957 |